Literature DB >> 4814896

Ultrastructural features on the platelet response to phorbol myristate acetate.

R D Estensen, J G White.   

Abstract

Phorbol myristate acetate (PMA) the active ingredient of croton oil, is a potent stimulus of irreversible platelet aggregation. The present study has examined the effects of PMA on platelet fine structure during aggregation and after incubation. PMA appears to act primarily on channels of the open canalicular system and intracellular granules. Small amounts of the agent cause dilatation of some open channels and conversion of granules to swollen vacuoles. Platelet discoid shape is not affected significantly by the changes in channels and vacuoles, and aggregation occurs without shape change. EDTA inhibits PMA-induced aggregation but does not prevent the conversion of platelet granules to vacuoles. In unstirred systems PMA causes similar changes in platelet fine structure and spontaneous aggregation. The drug appears to affect the permeability barrier separating granule contents from open channels, thereby leading to osmotic swelling of the storage organelles. PMA is the first agent observed to have a selective influence on the stability of platelet granules.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4814896      PMCID: PMC1910799     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  8 in total

1.  Platelet interaction with bacteria. I. Reaction phases and effects of inhibitors.

Authors:  C C Clawson; J G White
Journal:  Am J Pathol       Date:  1971-11       Impact factor: 4.307

Review 2.  Tumor-promoting agents in two-stage carcinogenesis.

Authors:  B L Van Duuren
Journal:  Prog Exp Tumor Res       Date:  1969

3.  The interplatelet zone.

Authors:  J G White
Journal:  Am J Pathol       Date:  1970-01       Impact factor: 4.307

4.  Uptake of latex particles by blood platelets: phagocytosis or sequestration?

Authors:  J G White
Journal:  Am J Pathol       Date:  1972-12       Impact factor: 4.307

5.  Degranulation of discoid platelets.

Authors:  J G White; R D Estensen
Journal:  Am J Pathol       Date:  1972-08       Impact factor: 4.307

6.  Fine structural alterations induced in platelets by adenosine diphosphate.

Authors:  J G White
Journal:  Blood       Date:  1968-05       Impact factor: 22.113

7.  Studies on lysosomes. X. Effects of tumor-promoting agents upon biological and artificial membrane systems.

Authors:  G Weissmann; W Troll; B L Van Duuren; G Sessa
Journal:  Biochem Pharmacol       Date:  1968-12       Impact factor: 5.858

8.  Cocarcinogenic principles from the seed oil of Croton tiglium and from other Euphorbiaceae.

Authors:  E Hecker
Journal:  Cancer Res       Date:  1968-11       Impact factor: 12.701

  8 in total
  16 in total

1.  The influence of prostaglandin endoperoxides on platelet ultrastructure.

Authors:  J M Gerrard; J G White
Journal:  Am J Pathol       Date:  1975-08       Impact factor: 4.307

2.  The effect of phorbol myristate acetate on the metabolism and ultrastructure of human alveolar macrophages.

Authors:  J R Hoidal; J E Repine; G D Beall; F L Rasp; J G White
Journal:  Am J Pathol       Date:  1978-06       Impact factor: 4.307

3.  Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.

Authors:  S Ohkubo; N Nakahata; Y Ohizumi
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

4.  The ultrastructure of defective human platelets.

Authors:  J G White; J M Gerrard
Journal:  Mol Cell Biochem       Date:  1978-11-01       Impact factor: 3.396

5.  The effects of 1-oleoyl-2-acetylglycerol on platelet protein phosphorylation and platelet ultrastructure.

Authors:  L L Friesen; J M Gerrard
Journal:  Am J Pathol       Date:  1985-10       Impact factor: 4.307

6.  Phorbol myristate acetate: in vivo effects upon neutrophils, platelets, and lung.

Authors:  J T O'Flaherty; S Cousart; A S Lineberger; E Bond; D A Bass; L R DeChatelet; E S Leake; C E McCall
Journal:  Am J Pathol       Date:  1980-10       Impact factor: 4.307

7.  Plasminogen activator induction and platelet aggregation by phorbol and some of its derivatives: correlation with skin irritancy and tumor-promoting activity.

Authors:  P J Brynes; R Schmidt; E Hecker
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

8.  Selective labilization of specific granules in polymorphonuclear leukocytes by phorbol myristate acetate.

Authors:  J G White; R D Estensen
Journal:  Am J Pathol       Date:  1974-04       Impact factor: 4.307

9.  Cytochemical electron microscopic studies of the action of phorbol myristate acetate on platelets.

Authors:  J G White; R D Estensen
Journal:  Am J Pathol       Date:  1974-03       Impact factor: 4.307

10.  Loss of intercalated membrane particles by treatment with phorbols.

Authors:  D Zucker-Franklin; Z F Nabi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.